You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV GT6

Showing 1 - 25 of 4,296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

Recruiting
  • Hepatitis C
  • Epclusa (sofosbuvir and velpatasvir)
  • Guangzhou, Guangdong, China
    Deparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)

Completed
Has Results
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
  • (no location specified)
Jan 15, 2021

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Compensated Cirrhosis Trial in Bangkok (Grazaoprevir/Elbasavir, Grazaoprevir/Elbasavir/RBV)

Unknown status
  • Compensated Cirrhosis
  • Bangkok, Thailand
  • +1 more
Feb 11, 2020

HCV Microfluidic Diagnostics

Active, not recruiting
  • Hepatitis C
    • Kingston upon Hull, United Kingdom
      University of Hull
    Sep 14, 2023

    Eliminating HCV Infection Among PWUD

    Recruiting
    • Hepatitis C, Chronic
    • Drug Use
    • Vancouver, British Columbia, Canada
      Vancouver Infectious Diseases Centre
    Jul 22, 2022

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

    Completed
    Has Results
    • Hepatitis C Virus (HCV)
    • Glecaprevir/pibrentasvir adult formulation
    • Glecaprevir/pibrentasvir pediatric formulation
    • San Francisco, California
    • +37 more
    Sep 19, 2022

    Hepatitis C Trial in Toronto (HCV care provided by hospitalist during acute psychiatric admission)

    Recruiting
    • Hepatitis C
    • HCV care provided by hospitalist during acute psychiatric admission
    • Toronto, Ontario, Canada
      Centre for Addiction and Mental Health
    Apr 28, 2022

    Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    Has Results
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021

    Hyperglycemia and HRV in DMD - Longitudinal Aim

    Not yet recruiting
    • Duchenne Muscular Dystrophy
    • wearable technology
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Oct 16, 2023

    Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

    Not yet recruiting
    • Duchenne Muscular Dystrophy
    • wearable technology
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Nov 3, 2023

    Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A), Placebo to Grazoprevir 100 mg/Elbasvir 50 mg

    Completed
    Has Results
    • Chronic Hepatitis C
    • Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)
    • Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet
    • (no location specified)
    Nov 11, 2019

    Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

    Completed
    • Hepatitis C
    • Bradford, United Kingdom
    • +3 more
    Jan 4, 2023

    Type 2 Diabetes, Obesity Trial in Tbilisi (MAGNET System, DI Bio-fragmentable)

    Recruiting
    • Type 2 Diabetes
    • Obesity
    • MAGNET System, DI Bio-fragmentable
    • Tbilisi, Georgia
      Innova Medical Center
    Jan 11, 2023

    Hepatitis C Trial (Grazoprevir, Uprifosbuvir, Elbasvir)

    Completed
    Has Results
    • Hepatitis C
    • (no location specified)
    Jul 18, 2019

    Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

    Recruiting
    • Chronic Hepatitis C
    • Chronic Hepatitis B
    • Tenofovir Alafenamide 25 MG
    • Sofosbuvir / Velpatasvir
    • Beijing, Beijing, China
      Peking University First Hospital
    Aug 2, 2021

    Oral Glecaprevir/Pibrentasvir Tablet In Pediatric And Adult

    Completed
    • Hepatitis C Virus (HCV)
      • Chelyabinsk, Russian Federation
      • +5 more
      Jun 8, 2022

      Heart Defects Trial in Edmonton (Physical activity measures via Actigraph GT3X+ accelerometers for 7 consecutive days)

      Completed
      • Heart Defects
      • Physical activity measures via Actigraph GT3X+ accelerometers for 7 consecutive days
      • Edmonton, Alberta, Canada
        Stollery Children's Hospital
      Jun 16, 2022

      Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

      Completed
      • Hepatitis C, Chronic
      • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
      • Riyadh, Saudi Arabia
        King Fahad Medical City
      Nov 18, 2020

      HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

      Recruiting
      • HCV
      • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
      • Cairo, Egypt
        Faculty of Medicine, Ain-Shams University Research Institute-Cli
      May 2, 2023

      Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)

      Completed
      Has Results
      • Chronic HCV Infection
      • Elbasvir/Grazoprevir Fixed Dose Combination
      • Clermont-Ferrand, France
        CHU Clermont-Ferrand
      Sep 9, 2020